Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Net Cash Flow: 2019-2025

Historic Net Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $1.9 million.

  • Burning Rock Biotech's Net Cash Flow rose 111.71% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.9 million, marking a year-over-year decrease of 1268.24%. This contributed to the annual value of -$13.3 million for FY2024, which is 70.02% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Net Cash Flow is $1.9 million, which was up 102.85% from -$67.2 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Net Cash Flow registered a high of $26.1 million during Q1 2021, and its lowest value of -$295.7 million during Q3 2023.
  • Its 3-year average for Net Cash Flow is -$44.6 million, with a median of -$16.4 million in 2024.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 206.47% in 2024, then slumped by 1,089.38% in 2025.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Net Cash Flow stood at -$29.2 million in 2021, then climbed by 22.08% to -$22.8 million in 2022, then surged by 88.70% to -$2.6 million in 2023, then skyrocketed by 196.85% to $2.5 million in 2024, then skyrocketed by 111.71% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$67.2 million for Q2 2025, and -$25.1 million during Q1 2025.